These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1634905)

  • 1. Dopaminergic insufficiency reflecting cerebral ageing: value of a dopaminergic agonist, piribedil.
    Ollat H
    J Neurol; 1992; 239 Suppl 1():S13-6. PubMed ID: 1634905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive skill learning in healthy older adults after 2 months of double-blind treatment with piribedil.
    Peretti CS; Gierski F; Harrois S
    Psychopharmacology (Berl); 2004 Nov; 176(2):175-81. PubMed ID: 15138753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restoration of brain protein synthesis in mature and aged rats by a DA agonist, piribedil.
    Bustany P; Trenque T; Crambes O; Moulin M
    Fundam Clin Pharmacol; 1995; 9(5):458-68. PubMed ID: 8617410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of piribedil, a D-2 dopaminergic agonist, on dopamine, amino acids, and free radicals in gerbil brain after cerebral ischemia.
    Delbarre B; Delbarre G; Rochat C; Calinon F
    Mol Chem Neuropathol; 1995 Sep; 26(1):43-52. PubMed ID: 8588823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a dopaminergic agonist, piribedil (Trivastal 50 mg LP), on visual and spatial integration in elderly subjects.
    Corbe C; Arnaud F; Brault Y; Janiak-Bolzinger C
    J Neurol; 1992; 239 Suppl 1():S22-7. PubMed ID: 1634908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parkinsonian apathy responds to dopaminergic stimulation of D2/D3 receptors with piribedil.
    Thobois S; Lhommée E; Klinger H; Ardouin C; Schmitt E; Bichon A; Kistner A; Castrioto A; Xie J; Fraix V; Pelissier P; Chabardes S; Mertens P; Quesada JL; Bosson JL; Pollak P; Broussolle E; Krack P
    Brain; 2013 May; 136(Pt 5):1568-77. PubMed ID: 23543483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a dopaminergic agonist (piribedil) on cerebral blood flow in man.
    Güell A; Géraud G; Jauzac P; Victor G; Arné-Bès MC
    J Cereb Blood Flow Metab; 1982; 2(2):255-7. PubMed ID: 7076737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Piribedil, dopaminergic agonist and the cerebral neurovascular syndrom of the aging man (author's transl)].
    Babeau P; Pras P; Serizet A
    Sem Hop; 1980 Jan 18-25; 56(3-4):188-92. PubMed ID: 6244655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the dopamine agonist piribedil on prefrontal temporal cortical network function in normal aging as assessed by verbal fluency.
    Gierski F; Peretti CS; Ergis AM
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):262-8. PubMed ID: 16876301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral circulatory and metabolic effects of piribedil.
    McCulloch J; Edvinsson L
    Eur J Pharmacol; 1980 Sep; 66(4):327-37. PubMed ID: 7418723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Piribedil enhances frontocortical and hippocampal release of acetylcholine in freely moving rats by blockade of alpha 2A-adrenoceptors: a dialysis comparison to talipexole and quinelorane in the absence of acetylcholinesterase inhibitors.
    Gobert A; Di Cara B; Cistarelli L; Millan MJ
    J Pharmacol Exp Ther; 2003 Apr; 305(1):338-46. PubMed ID: 12649387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of dopaminergic tone in postmenopausal women: effects of piribedil on anterior pituitary hormones.
    De Marinis L; Mancini A; Calabrò F; Sciuto R; Fiumara C; Zuppi P; Saporosi A; Barini A; Menini E
    Horm Metab Res; 1991 Jan; 23(1):30-4. PubMed ID: 1849868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Responses of central neurones to piribedil and 2-bromo-alpha-ergocryptine: comparison with dopamine and apomorphine.
    Bioulac B; Fumoux F; Ferron A; Vincent JD
    Eur J Pharmacol; 1978 Sep; 51(1):29-37. PubMed ID: 699972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amphetamine- type reinforcement by dopaminergic agonists in the rat.
    Yokel RA; Wise RA
    Psychopharmacology (Berl); 1978 Jul; 58(3):289-96. PubMed ID: 98800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dopamine agonists lisuride and piribedil protect against behavioural and histological changes following 4-vessel occlusion in the rat.
    Caldwell MA; Reymann JM; Bentue-Ferrer D; Allain H; Leonard BE
    Neuropsychobiology; 1996; 34(3):117-24. PubMed ID: 8916068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apomorphine and piribedil in rats: biochemical and pharmacologic studies.
    Butterworth RF; Poignant JC; Barbeau A
    Adv Neurol; 1975; 9():307-26. PubMed ID: 1170716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of central dopaminergic mechanisms in piribedil and clonidine induced hypothermia in the rat.
    Reid JL; Lewis PJ; Myers MG
    Neuropharmacology; 1975 Mar; 14(3):215-20. PubMed ID: 1134626
    [No Abstract]   [Full Text] [Related]  

  • 18. The influence of piribedil (ET495) on components of locomotor activity.
    Jenner P; Marsden CD
    Eur J Pharmacol; 1975 Aug; 33(1):211-5. PubMed ID: 1175688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cognitive disturbances and dysfunction of neuromediator systems in cerebral vascular insufficiency after treatment with pronoran].
    Bugrova SG; Novikov AE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(8):63-5. PubMed ID: 18689025
    [No Abstract]   [Full Text] [Related]  

  • 20. Dopamine-agonist drugs and cerebral electrical activity in the rabbit.
    Savoldi F; Tartara A; Bo P
    Farmaco Sci; 1979 Jun; 34(6):526-34. PubMed ID: 572783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.